Vironova AB Information

Founded in Stockholm in 2005, Vironova is a world leading partner to the global life science community in the development of novel therapies for tomorrow. By combining hardware and software solutions for advanced electron microscopy analysis, we support our partners through the whole value chain. From initial sample preparation to imaging and final analytical result, our dedicated team provide insightful and actionable data. We empower clients to make better-informed decisions, to create value and ensure safety for patients worldwide. TEM has previously been an expensive and complex practice to use in gene therapy, vaccine and drug development. At Vironova, we focus on supporting our partners by lowering technical thresholds, minimizing analytical complexity and provide business critical insights for the development of biopharmaceuticals targeting previously untreatable conditions. We are experts in what we do and put technology and innovation at our core. From initial sample preparation to imaging and final analytical result, our dedicated team will cut time and cost to market for our clients, and ultimately create value for patients worldwide. We are on a mission to build trust in the therapies of tomorrow by making the invisible visible today. Vironova provides fast and cost-effective electron microscopy services enabled by our own software and hardware. Our services are performed in the world’s only GMP-certified TEM laboratory, creating reliable and traceable results. This makes us the only company with a full-service value chain offer from start to finish. By combining deep industry expertise and data-driven insights, we help clients solve real needs by making the subvisible accessible. With over 200 established customer relationships, Vironova is a leading partner for the life science industry. We have a strong acquisition pipeline of new clients and deep inroads with the global research community.